X-Vax Technology, Inc. Email Format
Biotechnology ResearchFlorida, United States11-50 Employees
X-Vax Technology, Inc. is a small biotechnology research company based in Palm Beach Gardens, Florida. It focuses on developing vaccines against pathogens acquired through mucosal infection, with herpes identified as a key target. The company aims to induce antibodies that mediate the killing of infected cells, supported by data from multiple preclinical models. X-Vax has pursued early clinical evaluation, announcing the launch of a Phase 1 study in 2019. A 2026 report notes a leadership change with the departure of its chief executive.